一种洛匹那韦超细微粒制备设备及制备方法
本发明适用于药物化学技术领域,提供了一种洛匹那韦超细微粒制备设备及制备方法;所述洛匹那韦超细微粒制备方法,包括以下步骤:原料混合:将洛匹那韦原料粉末加入到有机溶剂中,超声处理后得到洛匹那韦初始溶液;预热排气:设定结晶装置温度,预热30~50min后排净结晶装置内空气,然后升压稳定至8~14MP;结晶:将初始药物溶液和CO2通入结晶装置,反应结束后以6~8L/min继续通入CO2,0.5~1.5h后卸压,收集洛匹那韦超细微粒。本发明制备过程不会引发药物成分的降解和化学衍生反应,可以保证药物的化学结构保持一致。 The invention is suitable for the technical...
Gespeichert in:
Format: | Patent |
---|---|
Sprache: | chi |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | 本发明适用于药物化学技术领域,提供了一种洛匹那韦超细微粒制备设备及制备方法;所述洛匹那韦超细微粒制备方法,包括以下步骤:原料混合:将洛匹那韦原料粉末加入到有机溶剂中,超声处理后得到洛匹那韦初始溶液;预热排气:设定结晶装置温度,预热30~50min后排净结晶装置内空气,然后升压稳定至8~14MP;结晶:将初始药物溶液和CO2通入结晶装置,反应结束后以6~8L/min继续通入CO2,0.5~1.5h后卸压,收集洛匹那韦超细微粒。本发明制备过程不会引发药物成分的降解和化学衍生反应,可以保证药物的化学结构保持一致。
The invention is suitable for the technical field of medicinal chemistry, and provides lopinavir ultrafine particle preparation equipment and a preparation method. The preparation method of the lopinavir ultrafine particles comprises the following steps: mixing raw materials: adding lopinavir raw material powder into an organic solvent, and carrying out ultrasonic treatment to obtain a lopinavir initial solution; preheating and exhausting: setting the temperature of the crystallization device, preheating for 30-50 minutes, exhausting air in the crystallization device, and then boosting and stabilizing to 8-14 MP; and crystallization: introducing the initial drug solution and CO2 into a crystallization device, continuously introducing CO2 at the speed of 6-8 |
---|